Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemiaLeukemia, LymphoidLeukemia, Lymphocytic, Chronic, B-CellLeukemia, Myeloid, AcuteLeukemia, MyeloidAcute DiseaseCytarabineMyeloid-Lymphoid Leukemia ProteinAsparaginaseGene Expression Regulation, LeukemicDaunorubicinLeukemia, Biphenotypic, AcuteRemission InductionBone MarrowTranslocation, GeneticLeukemia-Lymphoma, Adult T-CellLeukemia, B-CellPrognosisVincristineKaryotyping6-MercaptopurineRemission, SpontaneousPhiladelphia ChromosomeLeukemia, Monocytic, AcuteBurkitt LymphomaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveAntineoplastic Combined Chemotherapy ProtocolsMethotrexateAntineoplastic AgentsLeukemia, T-CellChromosome AberrationsLeukemic InfiltrationImmunophenotypingB-LymphocytesPrecursor B-Cell Lymphoblastic Leukemia-LymphomaChromosomes, Human, Pair 11DNA, NeoplasmLeukemia, ExperimentalVidarabineTreatment OutcomeProto-OncogenesRecurrenceNeoplasm ProteinsOncogene Proteins, FusionBlast CrisisGene RearrangementLymphocytes, NullPrednisoneFusion Proteins, bcr-ablfms-Like Tyrosine Kinase 3Immunoglobulin Heavy ChainsSurvival AnalysisLymphomaCytogenetic AnalysisFlow CytometryDNA NucleotidylexotransferaseMitoxantroneCore Binding Factor Alpha 2 SubunitCyclophosphamideSurvival RateReceptors, Antigen, B-CellMutationTumor Cells, CulturedCyclin-Dependent Kinase Inhibitor p15Leukemia, Hairy CellZAP-70 Protein-Tyrosine KinaseBone Marrow TransplantationDrug Resistance, NeoplasmArabinonucleosidesDrug Administration ScheduleRosette FormationChlorambucilDual Specificity Phosphatase 2Chromosomes, Human, 6-12 and XNeoplasm, ResidualT-LymphocytesDisease-Free SurvivalLeukemia Virus, MurineChromosomes, Human, Pair 9Base SequenceAnisocoriaLymphocytesAmsacrineAntigens, NeoplasmCytogeneticsSalvage TherapyMolecular Sequence DataTime FactorsNervous System NeoplasmsCorneal PerforationProto-Oncogene ProteinsAntigens, CD5Transplantation, HomologousThioguaninePolymerase Chain ReactionCell Transformation, NeoplasticDexamethasoneAntibodies, MonoclonalDoxorubicin